After the fluctuations of marijuana stocks over the last year, Aphria (NYSE:APHA) stock still trades more than 50% below its 52-week high. Investors sold off Aphria stock, as many questioned whether APHA was a “shell game”after it bought assets in Latin America.

However, the executives who drove that purchase have left Aphria. The company has now hired a well-regarded executive as its interim CEO. Due to its current multiple and improved strategic decision-making, Aphria stock could move much higher as the company’s reputation improves.

After months of sizzling gains, marijuana stocks cooled off in a big way in May. The Horizons Marijuana Life Sciences ETF, the first tradable cannabis ETF that holds more than four dozen pot stocks of various weightings, fell by more than 13% in May after having tripled the S&P 500's return through the first four months of the year.

Though it's up for debate, legal marijuana might be the growth opportunity of our generation, with Wall Street analysts expecting global sales to grow by four to six times what was generated in 2018. This could put the cannabis industry on par with global giants like the soda industry roughly a decade from now. These estimates, along with the public's rapidly changing perception of pot, have investors excited about the long-term prospects for marijuana stocks.

June 2019 might hold some surprises for cannabis stocks. With the recent market downtrend, there are many great cannabis stocks potentially selling at a discount. It's become evident that cannabis is now consolidating and potentially setting up for the next wave of volatility.

Whether that wave proves to be bullish or not is yet to be determined. For June 2019, there are a few stocks worth watching.

Here is a short list of stocks to look out for June:

Tilray (NASDAQ: TLRY) stock has fallen over 47% in the year so far. In the mid-2018, the shares have started the downward trend as the question arose about the safety of cannabinoid that is found in marijuana for human consumption. This question still remained unanswered as the Federal Drug Administration recently cast its doubts about the risks of cannabis food products in its first public hearing.

TGOD stock is on the rise at present; shares are up 7.87% and selling for $2.75 USD on the OTCQX.

As a sector-wide bearish trend hit the cannabis market, The Green Organic Dutchman (TSX:TGOD) (OTCQX:TGODF), along with many of its peers, declined significantly in the latter half of May.

In that period, TGOD stock lost approximately 20%.

Canada’s legalization of pot edibles later this year is facing an even more shambolic start than the dried flower market, which is still struggling to meet demand, according to industry players.

“At least that time we knew what the permissible product types were going to be and were already making them in the medical context,” said cannabis lawyer Trina Fraser, a partner at Brazeau Seller Law in Ottawa.

Canada will add edibles, extracts and topicals to the list of legal cannabis products no later than Oct. 17. Many analysts agree these products will generate better demand and margins than dried flower. But the federal government has not yet issued regulations for the new formats, making it difficult for producers to prepare lest they unknowingly violate some rule.

Aurora Cannabis Inc. (TSX:ACB) (NYSE:ACB) is one of the Canadian cannabis stocks and is the second-largest Canadian cultivator by market cap. The Company has invested a significant amount of money into innovation and efficiency, which makes them attractive as an investment. In an article published on May 24, 2019, we discussed how Aurora Cannabis has a medical cannabis market edge.

Today, many marketers and retailers, seem to think that their brand(s) can become supercharged just by adding two words to their brand(s) name. More awareness. More sales. Significantly increased revenues! All they have to do is to add the following: "CBD infused (insert the brand name here)". Beer, alcohol, candy, foods, lotions… pet food! Recent market reports, however, back up this phenomenon. Recent predictions for the CBD infused products market have created much enthusiasm and the optimists not only see the glass as half full… but they see it as overflowing!

The past month has not been a great time for weed stocks. Following four months of solid gains, the sector as a whole shed about 11% of its value, following disappointing quarterly reports from several major growers.

For years, marijuana stocks have been growing earnings at a frightening pace, while also running massive net and operating losses. Now, however, some of the top companies in the industry have been trimming their expenses, resulting in an increasingly positive profit picture. The following are three such stocks that, if everything goes right, could be very profitable by the end of 2020.